ALLR — ALLARITY THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ALLARITY THERAPEUTICS INC (ALLR)
ALLARITY THERAPEUTICS INC (ALLR) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $148,744. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ALLR
How many top investors track ALLR
Only 1 tracked investor report this position.
ALLR Ownership Composition
How ALLARITY THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting ALLR
- Ken GriffinDec 31, 2025Citadel AdvisorsShares84.6KValue$91.4K% Portfolio0.00%
Recent activity
- Sold$0(-100.00%)May 15, 2026
- Reduced$91.4K(-10.15%)Feb 17, 2026
- New$148.7KNov 14, 2025
Frequently asked questions
- How many institutional investors hold ALLR?
- 1 tracked institutional investor disclosed a position in ALLR (ALLARITY THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ALLR?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ALLR, valued at $148,744.
- Did institutional ownership of ALLR increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 1 reduced, and 1 fully exited ALLR.
- Where does this ALLR ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.